Genetic defects underlying junctional epidermolysis bullosa (JEB) can also cause kidney-urinary tract symptoms, a case series reports. Researchers recommend…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
A 36-year-old woman with epidermolysis bullosa acquisita or EBA — a non-genetic type of epidermolysis bullosa (EB) — was…
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion that recommends the approval in Europe…
Plant-based kaempferol — a compound with antioxidant and anti-inflammatory properties — enhanced the production in skin cells of C7,…
An imbalance both of immune signaling proteins and mediators of the itch response was found in the bloodstream of people…
Amryt Pharma has completed its rolling submission of an application to the U.S. Food and Drug Administration seeking the approval…
This month’s Plunge for Elodie will be a virtual event for a first time,…
An analysis of the control group from the ESSENCE Phase 3 clinical trial, which tested the topical cream…